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Effect of case management on neonatal mortality
due to sepsis and pneumonia
Anita K M Zaidi1*, Hammad A Ganatra1, Sana Syed1, Simon Cousens2, Anne CC Lee3, Robert Black3,
Zulfiqar A Bhutta1, Joy E Lawn4
Abstract
Background: Each year almost one million newborns die from infections, mostly in low-income countries.
Timely case management would save many lives but the relative mortality effect of varying strategies is
unknown. We have estimated the effect of providing oral, or injectable antibiotics at home or in first-level
facilities, and of in-patient hospital care on neonatal mortality from pneumonia and sepsis for use in the
Lives Saved Tool (LiST).
Methods: We conducted systematic searches of multiple databases to identify relevant studies with mortality data.
Standardized abstraction tables were used and study quality assessed by adapted GRADE criteria. Meta-analyses
were undertaken where appropriate. For interventions with biological plausibility but low quality evidence, a Delphi
process was undertaken to estimate effectiveness.
Results: Searches of 2876 titles identified 7 studies. Among these, 4 evaluated oral antibiotics for neonatal
pneumonia in non-randomised, concurrently controlled designs. Meta-analysis suggested reductions in all-
cause neonatal mortality (RR 0.75 95% CI 0.64- 0.89; 4 studies) and neonatal pneumonia-specific mortality (RR
0.58 95% CI 0.41- 0.82; 3 studies). Two studies (1 RCT, 1 observational study), evaluated community-based
neonatal care packages including injectable antibiotics and reported mortality reductions of 44% (RR= 0.56,
95% CI 0.41-0.77) and 34% (RR =0.66, 95% CI 0.47-0.93), but the interpretation of these results is complicated
by co-interventions. A third, clinic-based, study reported a case-fatality ratio of 3.3% among neonates treated
with injectable antibiotics as outpatients. No studies were identified evaluating injectable antibiotics alone for
neonatal pneumonia. Delphi consensus (median from 20 respondents) effects on sepsis-specific mortality
were 30% reduction for oral antibiotics, 65% for injectable antibiotics and 75% for injectable antibiotics on
pneumonia-specific mortality. No trials were identified assessing effect of hospital management for neonatal
infections and Delphi consensus suggested 80%, and 90% reductions for sepsis and pneumonia-specific
mortality respectively.
Conclusion: Oral antibiotics administered in the community are effective for neonatal pneumonia mortality
reduction based on a meta-analysis, but expert opinion suggests much higher impact from injectable antibiotics in
the community or primary care level and even higher for facility-based care. Despite feasibility and low cost, these
interventions are not widely available in many low income countries.
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Background
Deaths occurring in the neonatal period each year
account for 41% (3.6 million) of all deaths in children
under 5 years [1]. The majority of these deaths occur in
low income countries and almost 1 million of these
deaths are attributable to infectious causes including
neonatal sepsis, meningitis and pneumonia [1]. These
deaths occur because of lack of preventive care (clean
birth care, breastfeeding) and appropriate case manage-
ment [2]. Delays in treating neonatal infections of even
a few hours may be fatal. Delays in illness recognition
and care seeking, a dearth of primary health care provi-
ders, and limited access to facility care contribute to
these deaths [3]. Recent trials have demonstrated the
effect of community-based packages for prevention and
treatment of neonatal bacterial infections, with the
potential to save many lives [4,5].
Therapy with appropriate antibiotics and supportive
management in neonatal nurseries is the cornerstone of
management of neonatal sepsis and pneumonia, with
strong biological plausibility that such therapy saves lives.
Yet the quality of evidence is understandably affected by
the ethical impossibility of undertaking randomized trials
of antibiotic management compared with no antibiotic
management. Nevertheless, given the limited access to
care for sick neonates in low income countries, it is
important to assess the potential mortality effect of oral
antibiotics and injectable antibiotics delivered in domi-
ciliary or primary care settings. Case management for
hospitalized neonates is more expensive, but to guide
policy and program investments we also need to know
how much more effective it is compared to care delivered
at home or in primary care settings.
The objective of this review is to provide estimates of
the effectiveness of three interventions in preventing
neonatal deaths from severe infection: (i) case manage-
ment with oral antibiotic therapy alone for pneumonia
and sepsis; (ii) case management with injectable antibio-
tics (± oral antibiotics) as an outpatient or at home for
neonatal sepsis /meningitis and pneumonia; and (iii)
hospital-based case management, including injectable
antibiotics, intravenous fluids, oxygen therapy, second
line injectable antibiotics if needed, and other supportive
therapy (Table 1). These mortality effect estimates are
used in the Lives Saved Tool (LiST) software, a user-
friendly tool that estimates the number of lives saved by
scaling up key interventions and helps in child survival
planning in low income countries [6,7].
Methods
Searches
We searched all published literature as per CHERG
systematic review guidelines[7]. Databases searched
were PubMed, Cochrane Libraries and WHO regional
databases from 1990 until April 2009 and included
publications in any language (Figure 1). Search terms
included various combinations of: sepsis, meningitis
and pneumonia. For sepsis and pneumonia manage-
ment at a hospital level we conducted two parallel
searches (Figures 2 and 3). These were broader as we
also wanted to identify studies reporting incidence and
case fatality ratios (CFR) for a related study on global
burden of neonatal sepsis. Titles and abstracts were
reviewed and studies were included if data on one of
the following outcomes was provided: all-cause mortal-
ity, sepsis/meningitis/pneumonia mortality and/or CFR.
Furthermore, extensive efforts were made to contact
investigators and program managers for unpublished
data.
Inclusion/exclusion criteria, abstraction
We reviewed all available observational studies, rando-
mized controlled trials, systematic reviews, and meta-
analyses, which included neonates and principally
involved the management of serious neonatal infections.
The search was limited to “humans”. We examined stu-
dies published from 1990 until April 2009.
We included randomized controlled trials, studies with
concurrent controls, and observational studies with no
control group if mortality outcomes were reported. All
studies meeting final inclusion criteria were double data
abstracted into a standardized form. We abstracted key
variables with regard to the study identifiers and con-
text, study design and limitations, intervention specifics,
and mortality outcomes. We assessed the quality of each
of these studies using a standard table employing an
adapted version of GRADE[8] developed by the Child
Health Epidemiology Reference Group (CHERG) [7].
For studies which reported mortality outcomes that
were not neonatal specific, we contacted the authors to
Table 1 Definitions of interventions reviewed
Oral antibiotic therapy alone
• Administration of oral antibiotics in the community for neonatal
sepsis, meningitis, or pneumonia
Injection therapy alone
• Administration of intramuscular antibiotics, at home or in first-
level facilities, for neonatal sepsis, meningitis, or pneumonia
Hospital-based management as an inpatient with supportive care
• Administration of intravenous antibiotics
○ Wider choice of antibiotics including broad spectrum antibiotics
○ Option of using frequent/higher dosage if needed to maintain
high blood antibiotic levels or coverage for meningitis,
○ Access to second-line antibiotic therapy for neonates with
treatment failure on first line antibiotics
• Intravenous access and administration of intravenous fluids if
needed
• Oxygen supplementation if required
• Access to appropriate diagnostic procedures, such as monitoring
of pulse, blood pressure, and oximetry reading, as well as
monitoring/correction of hypoglycemia if required
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request the neonatal-specific data. All studies that were
coded are included in Additional File 1.
Case definition of sepsis
During our review of selected studies we were unable to
find a standard definition for clinical neonatal sepsis or
pneumonia (Table 2). Each study used different criteria
although most are a variation on WHO IMCI approach.
We therefore decided to accept authors’ definitions of
sepsis and pneumonia, recognizing that these non-speci-
fic definitions lower mortality outcome estimates as
many “non-sepsis” cases are included in an effort to
maximize sensitivity.
Analyses and summary measures
All studies reporting mortality data for pneumonia and
sepsis management, in community and hospital settings,
were summarized according to the overall quality of evi-
dence for each outcome and each data input type using
an adapted version of the GRADE 21 protocol table [7].
When appropriate, we conducted meta-analyses to
obtain pooled estimates of the risk ratios, using either
the Mantel-Haenzsel or, when there was evidence of
heterogeneity, the DerSimonian-Laird random effects
estimator. 95% confidence intervals (CI) were also calcu-
lated. Statistical analyses were performed using STATA
10.0 (http://www.stata.com).
Delphi Process for Establishing Expert Consensus
For intervention-outcome combinations for which we
did not identify moderate quality evidence, we sought
expert consensus via the Delphi method. Individuals
invited to participate were experts in newborn health
and sepsis representing six WHO regions (South Asia,
Figure 1 Searches and screening for community based management of sepsis and pneumonia.
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Africa, Western Europe, Eastern Europe, North Amer-
ica, Australia), and including multiple disciplines -
international health, pediatric infectious diseases,
clinical neonatology, and general pediatrics. Twenty (of
twenty-three experts invited) agreed to participate in
the Delphi process. The questionnaire was developed
by JL, AZ, SC and SS, and refined after several rounds
of pilot testing. The questionnaire was sent by email
and included the background and aims of the Delphi
and estimates of effect that were available from the lit-
erature for different scenarios. The median response
and range were determined for each question. Consen-
sus was defined a priori as an interquartile range in
responses of not more than 30% for each question. For
those estimates not reaching consensus, the plan was
for results to be electronically distributed to the panel,
virtual discussion allowed, and a second round of
email questionnaires sent. However, consensus was
achieved after one round of questionnaires and subse-
quent rounds were not necessary.
Results
Studies identified
Our systematic searches for community management of
sepsis and pneumonia identified 2876 titles (Figure 1)
and after screening of titles, abstracts and relevant full
texts, we located 7 studies of interest (reported in 8
papers) [9-16]. We identified 4 non randomised concur-
rently controlled studies, which evaluated oral antibio-
tics for pneumonia (Table 5) [10,14-16]. Three of these
studies did not report disaggregated neonatal outcomes
in the primary papers, but neonatal outcomes were
available through abstracted forms from an earlier meta-
analysis by Sazawal et al [17]. For management of
neonatal sepsis using injectable antibiotics, we located 3
studies (reported in 4 papers) [9,11-13]. There was one
Figure 2 Searches and screening for hospital management of sepsis.
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observational primary clinic-based study without a con-
trol group [13], one RCT [12] and one non-randomised,
concurrently controlled study [9]. The fourth paper
reported observational data from individual infants eval-
uated during the RCT mentioned above and was not a
separate study [11]. All the studies were from high neo-
natal mortality regions.
In our search for hospital-based studies of sepsis we
found 55 studies from a total pool of 13998 studies
which reported sepsis and/or meningitis mortality out-
comes (Figure 2) [18-70]. For pneumonia, we found
two studies from a total pool of 94 studies (Figure 3)
[71,72].
The details of each study and quality assessment using
GRADE are summarised in Tables 3, 4, 5, and 6.
Evidence for effectiveness of oral antibiotic therapy alone
Unpublished neonatal data were obtained from the prin-
cipal investigators of the four studies identified and a
new meta-analysis was done to update that of Sazawal
et al[17]. We performed meta analyses for two out-
comes: oral antibiotics were associated with reductions
in both all-cause mortality (4 studies [10,14-16]: RR 0.75
95% CI 0.64- 0.89) (Figure 4) and pneumonia-specific
mortality (3 studies [10,15,16]: RR 0.58 95% CI 0.41-
0.82) (Figure 5). Limitations included non-randomiza-
tion, estimation of intervention coverage as precise
coverage estimates were not available;and variability
between studies of the intensity of co-interventions. We
found no studies of the effect of oral antibiotics on
sepsis-specific mortality. The Delphi consensus (median)
Figure 3 Searches and screening for hospital management of pneumonia.
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was for a 28% reduction in sepsis-specific mortality with
an interquartile range of 20% to 36.25% (Figure 6).
Evidence for effectiveness of injectable antibiotic therapy
(±oral antibiotics)
Three studies reported in four papers, were identified
(Table 6) [9,11-13]. One, an RCT[12] evaluated the
impact of a perinatal care package which included the
administration of injectable antibiotics in domiciliary
settings in situations where referral to hospital was not
possible. This trial reported a reduction in all-cause neo-
natal mortality of 34% (RR=0.66, 95%CI 0.47-0.93). A
second paper from the same study reported that the
CFR for neonates who were evaluated and actually trea-
ted with injectable antibiotics was 4.4% [11]. A non-
randomized, concurrently controlled study [9] also
evaluated the impact of a home-based neonatal care
package in which septic neonates were treated with
injectable antibiotics when referral to hospital was not
possible. The overall mortality reduction in the interven-
tion arm of the trial was calculated to be 44% (RR=0.56
95% CI 0.41-0.77). A third, uncontrolled study [13]
based in a primary care clinic reported a CFR of 3.3%
among septic children treated with injectable antibiotics.
In both of the community-based studies [9,12] injectable
antibiotics were only one component of comprehensive
Table 2 Varying definitions of neonatal sepsis used by
investigators and clinicians
Common signs of neonatal sepsis:
• Lethargy or irritability
• Poor feeding
• Vomiting
• Jaundice
• Respiratory distress
• Apnoea
• Fever or hypothermia
Definition of neonatal sepsis used by Bang et al (1999) [9]
Presence of two or more of the following signs:
• Weak or absent cry
• Weak or reduced suckling
• Drowsy or unconscious
baby
• Temperature more than
37.2°C or less than 35°C
• Diarrhoea or persistent vomiting or
abdominal distension
• Grunting or severe chest indrawing
• Respiratory rate of 60 or more
• Pus in skin or umbilicus
Definition of neonatal sepsis used by Baqui et al (2008) [12]
Presence of one or more of the following signs:
• Convulsions
• Unconsciousness
• Fever ≥ 38.3°C
• Breathing ≥ 60 per minute
• Body Temperature ≤ 35.3°C
• Many or severe skin pustules or blisters
on single large area, or pus or redness
with swelling Severe chest indrawing
Definition of sepsis by Young Infant Clinical Signs Study Group
(2008) [84]
Presence of one or more of the following signs:
• Difficulty feeding
• Convulsions
• Movement only when
stimulated
• Respiratory rate of 60 or
more
• Severe chest indrawing
• Temperature ≥ 37.5°C
• Temperature ≤ 35.5°C
Table 3 GRADE assessment of studies of effect of case management on cause specific neonatal mortality due to
pneumonia
Quality Assessment Summary of Findings
No. of Events Effect
No. of
studies
Design Limitations Consistency Generalizability
to Population
of Interest:
means to the
“population”
Generalizability
of the
Intervention of
interest
Intervention Control Relative Risk
(95% CI)
Mortality Pneumonia – community based oral antibiotic studies
4 1 randomized
3 Non
randomized -
concurrent
control
Studies are not
randomized,
coverage of
intervention are
estimates, exact data
not available,
intensity of co-
interventions varies
between studies
Findings from the 4
studies all show
direct mortality
reduction benefit,
although in 3 of the
4 studies included in
the meta analysis,
the effect reduction
is not significant.
Yes, studies were
all done in high
neonatal
mortality regions.
3 of the 4
studies show
direct effect on
pneumonia
specific mortality.
1 shows effect
on overall
neonatal
mortality
248/ 6542 63/
4538
*All-cause
mortality 0.75
(0.64- 0.89)
**Pneumonia
Specific 0.58
(0.41- 0.82)
Mortality Pneumonia - community based injectable antibiotic studies
No studies identified
Mortality Pneumonia - hospital-based case management
2 Both
observational
study design
Not trials CFR: 14.4% (28/195)
and 30.8% (8/26)
Both studies
from low income
South Asian
countries.
The study
reporting higher
CFR had high
proportion (60%)
of LBW babies.
N/A N/A N/A
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community-based newborn care packages, and therefore
the effectiveness of injectable antibiotics alone in the com-
munity cannot be reliably estimated. The Delphi consen-
sus for the effect of injectable antibiotics was for a 65%
reduction (interquartile range of 50-70%) in sepsis-specific
mortality and 75% reduction (interquartile range of 70-
81.25%) in pneumonia-specific mortality in community-
based settings (Figure 6).
Evidence for effectiveness of inpatient hospital case
management
We found no trials assessing the impact of hospital-
based case management and the observational studies of
hospital management showed wide variation in effect.
Searches conducted for studies reporting CFRs in neo-
nates with pneumonia in health facilities revealed very
few data. Two studies were identified with author-
defined neonatal pneumonia; both were from low
income, non-industrialised settings and reported CFRs
of 14.4% [72] and 30.8% [71].
CFRs for neonatal sepsis, adjusted for the proportion of
very low birth weight babies in the study, were plotted
against national percentage skilled delivery, as a proxy for
access to hospital-based case management of neonatal
sepsis. In countries with a high proportion of births
attended by skilled attendants, the predicted CFR for sep-
sis was 9.5%, whereas in countries with a low proportion
(<30%) skilled birth attendance, the predicted CFR for
sepsis with hospital care is 20-30% (Figure 7). A 68%
reduction in the CFR for neonatal sepsis is predicted as
one moves from 0% to100% skilled birth attendance. This
reduction is likely to under estimate the effect of hospi-
tal-based case management since skilled birth attendance
is likely to be a poor surrogate for effective facility case
management of neonatal infections, but was used in the
absence of coverage data for case management
Although the quality of evidence is low according to
GRADE criteria, the recommendation for case manage-
ment of neonatal infections is strong, and this is stan-
dard practice globally. Table 7 provides a summary of
Table 4 GRADE assessment of studies of case management on cause specific neonatal mortality due to neonatal sepsis
Quality Assessment Summary of Findings
No. of Events Effect
No. of
studies
Design Limitations Consistency Generalizability
to Population
of Interest
Generalizability of the
Intervention of interest
Intervention Control Relative
Risk
(95% CI)
Mortality Sepsis – community based oral antibiotic studies
No studies identified
Mortality Sepsis – community based injectable antibiotic studies
2 Observational 1 study has no control
group
Yes: both
show low
CFRs (3.3%,
4.4%)
Yes, both studies
were done in
high neonatal
mortality regions.
Direct 133/2211 N/A N/A
1 Non
randomized -
concurrent
control trial
Change in sepsis specific
mortality rate in
intervention and control
areas is not given
The results
of this study
were
consistent
with the
RCT
Yes, study was
done in a high
neonatal
mortality region.
Indirect 54/1783 113/
2048
0.56
(0.41-
0.77)
1 RCT Sepsis specific reduction
in mortality not given
Reported
similar
results as
study above
Yes, study was
done in a high
neonatal
mortality region.
Indirect 82/2812 125/
2872
0.22
(0.07-
0.71)
CFR=4.4%
Mortality Sepsis/Meningitis - case management in hospitals
55 All
observational
study designs
All observational with
varied study setting, from
high-income to low-
income countries. In low-
income countries self-
selecting populations
because most births
happen at community
level.
CFR range
from 67 to
6.7%
*NMR LEVEL5= 5
studies
NMR LEVEL4=17
studies
NMR LEVEL 3= 5
studies
NMR LEVEL2=5
studies
NMR LEVEL1=22
studies
Multi country=1
In countries with high
skilled attendance
hospital data
generalizable to all
population. But in low-
income countries, hospital
data not given as most
births at home
N/A N/A N/A
*NMR LEVELs (1=NMR <5 per 1000 live births, 2=NMR 6 to 15 per 100 live births, 3= NMR 15 to 30 per 100 live births, 4=NMR 31-45 per 100 live births 5=NMR
>45 per 100 live births.
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the effect of case management on neonatal sepsis and
pneumonia cause specific mortality, and GRADE of the
estimate. Therefore the Delphi process was used to pro-
vide estimates for the effect of hospital care. The Delphi
consensus was for a 80% reduction in sepsis-specific
mortality (interquartile range 75% to 85%), and a 90%
reduction in pneumonia-specific mortality (interquartile
range 88.75% to 95%) (Figure 6).
Discussion
Infections including sepsis, meningitis and pneumonia
are responsible for almost a million neonatal deaths
annually. Neonates are more susceptible to severe infec-
tions and the progression of disease is more rapid due
to developmental immunodeficiency, resulting in high
CFRs. Also, a significant proportion of infections may
arise early, after vertical transmission from the mother
[73]. Therefore, timely identification and appropriate
management with antibiotics is an important strategy to
reduce the burden of neonatal mortality due to infec-
tions. We have previously reported the evidence from
observational and experimental studies in low income
countries for community-based management of neonatal
infections (pneumonia and sepsis) with oral and inject-
able antibiotics [74-76]. We have now undertaken a sys-
tematic review of available evidence, including from
industrialized countries and facility settings, and where
the quality of evidence is low we have undertaken a Del-
phi expert process to estimate the cause-specific mortal-
ity effect.
Table 5 Summary of community-based studies for case management with oral antibiotics for and effect on cause
specific neonatal mortality due to pneumonia
Ref and
year
Country Setting Study
design
Therapy given Other
interventions
in package
Coverage of
antibiotic
case
management
(% of those
who need it)
Intervention
group (N/D)
Control
group
(N/D)
Effect size RR
(95 % CI)
RR of
Sepsis
specific
NMR
RR of
Pneumonia
specific
NMR
Pandey
1991
[16]
Nepal Rural Non
randomized
-concurrent
control
Cotrimoxazole
4 mg/kg BD for
5 days.
Chloramphenicol
if no
improvement
Maternal
education, and
15% measles
immunization
coverage of
children
<40-70%
(estimates as
per study PIs)
81/681 16/681 0.85
(0.65-
1.12)
0.89
(0.46-1.72)
Mtango
1986
[15]
Tanzania Rural Non
randomized
-concurrent
control
Cotrimoxazole
PO
Health
education to
mothers about
symptoms &
signs of ARI
and referring
severe cases to
the next higher
level of care.
<40-70%
(estimates as
per study PIs)
37/1638 7/1638 0.70
(0.47-
1.07)
0.44
(0.18-1.07)
Khan
1990
[14]
Pakistan Rural Non
randomized
-concurrent
control
CotrimoxazolePO Qualified nurses
monitored and
supervised
CHW activities
and with
assistance of
the CHWs,
conducted
frequent,
informal,
interactive
health
education
programs
<40-70%
(estimates as
per study PIs)
26/2690 9/686 0.74
(0.35 -
1.57)
Did not
report
pneumonia
specific
mortality
Bang
1990
[10]
India Rural Non
randomized
-concurrent
control
Cotrimoxazole 2.5
ml twice daily for
7 days
Mass health
education
about
childhood
pneumonia
76% (for
children <5)
104/1533 31/1533 0.70
(0.54-
0.91)
0.52
(0.33-0.82)
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This review of effectiveness of the interventions is
shaped in large part by the needs of the LiST model. In
that model, increasing coverage of an intervention
results in a reduction in deaths due to one or more spe-
cific causes or in reduction of a risk factor. Therefore
the reviews and the GRADE process used were designed
to develop estimates of the effect of an intervention in
reducing death due to specific causes. For more details
of the review methods, the adapted GRADE approach or
the LiST model see related publications [6,7].
To our knowledge, this is the first review providing
effectiveness estimates for case management options to
reduce neonatal deaths due to neonatal sepsis/meningi-
tis and pneumonia, in both community and facility set-
tings. Theodoratou et al have previously estimated
effectiveness of pneumonia case management in children
under 5 years but they did not disaggregate neonatal
mortality data from later child mortality [77]. The esti-
mated effect of community case management on pneu-
monia mortality in children under 5 years of age in the
analysis by Theodoratou et al is 70% (77). Oral antibio-
tics in community settings for neonatal pneumonia in
our analysis were associated with a 42% reduction in
pneumonia-specific mortality and a 25% reduction in
all-cause neonatal mortality based on a meta-analysis of
available trials. There is no evidence to estimate the
effect of oral antibiotics on sepsis-specific mortality, but
our Delphi process suggested a 28% reduction. Delphi-
derived estimates for the effects of management using
injectable antibiotics delivered in home or primary care
settings came out at 65% for sepsis-specific mortality
and 75% for pneumonia-specific mortality. These
Table 6 Summary of community-based studies including injectable antibiotics for case management of neonatal sepsis
(observational, quasi experimental, and RCT)
Ref and
year
Country Setting Study design Therapy
given
Other interventions in
package
Coverage
of
antibiotic
case mx
(% of
those
who need
it)
Intervention
group (N/D)
Control
group
(N/D)
Effect
size RR
(95% CI)
Bang
1999 [9]
India Rural Non-
randomized
concurrent
control study
Gentamicin
IM and
cotrimoxazole
Comprehensive perinatal
care package including
trained TBAs, VHWs
undertaking >6 home
visits, targeting of small
babies for extra support,
comm. mobilization for
healthy home behaviors
etc.
Years
1996-97
85% 685/
804
Years
1997-98
93% 913/
979
54/1783* 113/
2048*
0.56
(0.41-0.77)
Bhandari
1996 [13]
India Periurban/
urban
Observational Cephalexin
PO and
amikacin IM
None N/A 124/2007 Age
group =1-2
mths
None No effect
size can
be
calculated
CFR= 3.3%
Baqui
2008 [12]
Bangladesh Rural Cluster
randomized
trial
Procaine
penicillin and
gentamicin
Birth and newborn-care
preparedness postnatal
home visits for newborns
assessment on 1,3,7 days
of birth. Referral when
needed
41%
estimated
from
adequacy
surveys
82/2812 125/
2872
0.66
(0.47-0.93)
Baqui
2009 [11]
Bangladesh Rural Observational** Procaine
penicillin and
gentamicin
Referral for very severe
disease or possible very
severe disease with
multiple signs, by CHWs
to government subdistrict
hospitals. If the family was
unable to comply with
referral, the CHWs treated
local skin and umbilical
cord infections with
gentian violet and made
follow up visits to reassess
the infant.
N/A 9/204 24/112 0.22
(0.07-0.71)
CFR=4.4%
* Combined data from years 2 and 3 of trial i.e. 1996-1997 and 1997-1998.
**Observational data on individual infants evaluated during the cluster randomized trial by Baqui et al. Control group is families unable to comply with referral
and were not offered treatment with injectable antibiotics at home.
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Figure 4 Meta-analysis of observational studies comparing oral antibiotics versus none in the community setting for babies: All cause mortality.
Legend: Heterogeneity chi-squared = 1.17 (d.f. = 3) p = 0.760 I-squared (variation in RR attributable to heterogeneity) = 0.0% Test of RR=1 : z=
3.32 p = 0.001.
Figure 5 Meta-analysis of observational studies comparing oral antibiotics versus none in the community setting for babies: Pneumonia
mortality. Legend: Heterogeneity chi-squared = 2.16 (d.f. = 2) p = 0.339 I-squared (variation in RR attributable to heterogeneity) = 7.5% Test of
RR=1: z= 3.06 p = 0.002.
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Figure 6 Box plot of Delphi expert opinion estimates of reduction in neonatal cause specific mortality due to pneumonia and sepsis/meningitis.
Figure 7 Plot of neonatal sepsis CFR versus percent skilled delivery as a marker of access to facility care. Model fitted: outcome = log(CFR)
Covariates = Skilled attendant coverage and % babies vLBW Fitted line is predicted CFR for settings with % VLBW<30%. Predicted CFR at 0%
skilled attendance is 30%. Predicted CFR at 100% skilled attendance is 9.5%. % reduction = 68.5% Coefficient skilled attendance is 0.12 on the
log scale (95% CI -0.02 to -0.007); i.e. for each 1% increase in skilled attendance rate CFR is reduced by 1.1% (95% CI: 0.7% to 1.6%).
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estimates are biologically plausible and consistent with
published studies [9,12] which reported reductions in
all-cause neonatal mortality (sepsis plus other causes) of
34% and 44% respectively with community-based
packages including injectable antibiotics. CFRs reported
from observational studies of hospital case management
varied widely, from 6.7 to 67%. Our Delphi estimates
suggested an 80% mortality reduction in sepsis deaths
and a 90% reduction in pneumonia deaths with hospital
case management.
There were 4 effectiveness trials assessing the impact
of oral antibiotics on pneumonia-specific mortality in
the community. Only one of these studies was rando-
mized and the programmatic coverage of the interven-
tion had to be estimated as coverage data were not
routinely assessed or reported. The selection and inten-
sity of co-interventions was not uniform between the
studies. An additional limitation was the lack of clearly
defined cause-of-death definitions by the authors. How-
ever, the effect sizes were remarkably consistent with
each other, and therefore the evidence level was
upgraded to moderate.
GRADE guidelines rank the evidence relating to the
effect of injectable antibiotics on sepsis-specific mortal-
ity as low quality. The 3 studies identified were not
uniform with respect to study designs; one was an
effectiveness RCT, one was a non-randomized concur-
rent trial and the third was an observational study
describing the experience from primary care clinic
without a control group. Both the RCT [12] and the
non-randomized concurrent trial[9], involved concur-
rent co-interventions alongside the administration of
injectable antibiotics. This made it impossible to assess
the impact of injectable antibiotics alone on sepsis
mortality. Neither study reported the change in the
sepsis-specific mortality rate in the intervention arm
compared to control arm, and reported the impact on
all-cause neonatal mortality only. The absence of ran-
domization in one of the trials is a further limitation
[9]. The main limitation to the observational study in a
Table 7 Effect of case management on neonatal sepsis and pneumonia cause specific mortality, and GRADE of the
estimate
Effect on neonatal deaths due to pneumonia
Cause specific effect and 95% CI/ interquartile range:
Oral therapy 42% (18-59%,95% CI)
Injection therapy 75% (70-81% interquartile range on Delphi)
Hospital-based case management 90% (89-95% interquartile range on Delphi)
Quality of input evidence:
For oral therapy, moderate (3 low quality non-randomized concurrent control studies)
For the effects of injection therapy and full case management, the level of evidence is very low (based on Delphi).
Proximity of the data to cause specific mortality effect:
Moderate for oral therapy as several low quality but consistent studies; however, lack of consistency in cause-of-death definitions
Very low quality for injection therapy and full case management as these results are based on Delphi
Limitations of the evidence:
Interpretation of the data is limited by concurrent interventions particularly for studies with injection case management
Possible adverse effects:
Data not reviewed
Effect on neonatal deaths due to sepsis and meningitis
Cause specific effect and interquartile range:
Oral therapy 28% (20-36.25% interquartile range on Delphi)
Injection therapy 65% (50-70% interquartile range on Delphi)
Hospital-based management 80% (75-85% interquartile range on Delphi)
Quality of input evidence:
Very low (based on Delphi)
Proximity of the data to cause specific mortality effect:
Direct effect estimated by Delphi
Limitations of the evidence:
Lack of direct evidence on sepsis-specific mortality. Studies have evaluated injectable antibiotics as part of multiple co-intervention peri-natal care
packages.
Possible adverse effects:
Data not reviewed
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primary care clinic [13] was the absence of a control
arm in the study.
We identified no controlled trials assessing the effect
of hospital-based case management of neonatal infec-
tions. Such studies would be difficult or impossible to
implement in an ethical fashion. Thus studies were lim-
ited to reporting CFRs for neonatal sepsis and meningi-
tis. The studies were from varied settings, from both
industrialized and low income countries, and reported
widely varying CFRs. Only 2 of these observational stu-
dies reported CFRs for pneumonia. One of these studies
reported a very high CFR for pneumonia due, we
believe, to the high proportion of LBW babies in the
sample (60%).
We found some moderate quality evidence for inter-
vention packages including antibiotics in community
settings but ironically data are most lacking at facility
level, and district hospital level is a critical gap [78].
Unlike the LiST review on neonatal resuscitation which
identified several before-after studies of facility based
neonatal resuscitation reporting mortality data, we were
unable to find similar before-after studies on the effect
of hospital-based case management of sepsis/meningitis/
pneumonia. An understandable reason for this might be
the ethical constraints precluding such studies. However,
historical reviews from the pre-antibiotic era provide an
insight into the CFR associated with untreated sepsis in
facility settings. The best available evidence comes from
the series of papers from Yale Medical Center reporting
time trends for neonatal sepsis. These data show that in
the 1920s and 1930s the CFR for blood culture con-
firmed sepsis stood at 90% [79,80]. With the introduc-
tion of antibiotics, the CFR decreased to 45% by 1965
[81], and with the subsequent introduction of intensive
care units and advanced life support it came down to
16% by 1988[82], and 3% by 2003[83]. Such data high-
light the effectiveness of hospital-based management in
preventing neonatal mortality from sepsis.
Conclusion
As evident from our results, even oral or injectable anti-
biotics alone are highly effective in reducing deaths
from neonatal sepsis or pneumonia. These interventions
hold great potential to reduce the 1 million neonatal
deaths each year. If substantial reduction in neonatal
mortality is desired, both, community and facility-based
interventions are required, linked by functioning referral
systems, giving the potential to prevent hundreds of
thousands of avoidable newborn deaths every year.
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